A detailed history of Fairview Capital Investment Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fairview Capital Investment Management, LLC holds 3,407 shares of MRK stock, worth $338,826. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,407
Previous 2,896 17.65%
Holding current value
$338,826
Previous $358,000 7.82%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $56,797 - $65,903
511 Added 17.65%
3,407 $386,000
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $247,600 - $265,920
-2,000 Reduced 40.85%
2,896 $358,000
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $24,343 - $26,491
243 Added 5.22%
4,896 $533,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $43,543 - $48,585
423 Added 10.0%
4,653 $495,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $353,162 - $400,327
4,230 New
4,230 $385,000
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $214,394 - $235,780
-2,991 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $210,297 - $232,610
2,991 New
2,991 $232,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $173,324 - $192,354
-2,415 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $176,729 - $200,324
2,415 New
2,415 $200,000
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $206,807 - $286,644
-3,264 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $9,880 - $11,269
142 Added 4.55%
3,264 $271,000
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $4,827 - $5,602
-74 Reduced 2.32%
3,122 $238,000
Q3 2018

Nov 09, 2018

BUY
$57.69 - $67.84 $184,377 - $216,816
3,196 New
3,196 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fairview Capital Investment Management, LLC Portfolio

Follow Fairview Capital Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.